A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
出版年份 2014 全文链接
标题
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
作者
关键词
-
出版物
ONCOGENE
Volume 34, Issue 26, Pages 3357-3368
出版商
Springer Nature
发表日期
2014-09-01
DOI
10.1038/onc.2014.269
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
- (2013) Markus Brockmann et al. CANCER CELL
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
- (2012) J H Schulte et al. ONCOGENE
- A Modified RMCE-Compatible Rosa26 Locus for the Expression of Transgenes from Exogenous Promoters
- (2012) Jan S. Tchorz et al. PLoS One
- Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
- (2012) Agnes Rasmuson et al. PLoS One
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
- (2011) K. De Preter et al. CLINICAL CANCER RESEARCH
- High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
- (2011) J. H. Schulte et al. CLINICAL CANCER RESEARCH
- Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research
- (2011) Ingrid Øra et al. SEMINARS IN CANCER BIOLOGY
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2010) Julie R. Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: Results of German trials
- (2010) Thorsten Simon et al. PEDIATRIC BLOOD & CANCER
- Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
- (2009) J. H. Schulte et al. CANCER RESEARCH
- Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness
- (2009) F Cimmino et al. ONCOGENE
- MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
- (2009) P Mestdagh et al. ONCOGENE
- A novel and universal method for microRNA RT-qPCR data normalization
- (2009) Pieter Mestdagh et al. GENOME BIOLOGY
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- (2008) Frank Westermann et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now